Results 1 to 10 of about 1,569,839 (301)
Nature Reviews Disease Primers, 2020 Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse.
John Strang +2 more
exaly +9 more sources
Medication Treatment of Opioid Use Disorder [PDF]
Biological Psychiatry, 2020 Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
openaire +5 more sources
Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery [PDF]
Annals of Surgery OpenObjective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD +7 more
doaj +2 more sources
North Carolina Medical Journal, 2018 The current opioid epidemic is devastating to the lives of individuals, families, and communities, but there are effective treatment approaches available. Treatment that combines proven medications with behavioral therapies and other supports is giving many in North Carolina the opportunity to engage in successful recovery.
Smith, Worth, Kenny, House
openaire +4 more sources
Comorbid Opioid Use Disorder in Body Dysmorphic Disorder
European Psychiatry, 2022 Introduction Body Dysmorphic Disorder (BDD) is a severe and common disorder that consists of distressing or impairing preoccupation with nonexistent or slight flaws in one’s physical appearance.
J. Kim +4 more
doaj +1 more source
JAMA Network Open, 2023 This cross-sectional study uses data from the 2021 National Survey on Drug Use and Health to estimate the receipt of medication for opioid use disorder among US adults with past-year opioid use disorder.
Christopher M. Jones +4 more
semanticscholar +1 more source
Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes
Frontiers in Psychiatry, 2021 Objective: Substance use disorders remain highly stigmatized. Access to medications for opioid use disorder is poor. There are many barriers to expanding access including stigma and lack of medical education about substance use disorders. We enriched the
Holly Ann Russell +3 more
doaj +1 more source
Prevalence and predictors of suicidality among adults initiating office-based buprenorphine
Addiction Science & Clinical Practice, 2023 Background Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid use disorder (OUD) initiating office-
Michelle R. Lent +5 more
doaj +1 more source
Racial Inequality in Receipt of Medications for Opioid Use Disorder.
New England Journal of Medicine, 2023 BACKGROUND Since 2010, Black persons in the United States have had a greater increase in opioid overdose-related mortality than other groups, but national-level evidence characterizing racial and ethnic disparities in the use of medications for opioid ...
Michael L. Barnett +8 more
semanticscholar +1 more source
Patient evaluation of a smartphone application for telehealth care of opioid use disorder
Addiction Science & Clinical Practice, 2022 Background People with opioid use disorder (OUD) face barriers to entering and remaining in life-saving treatment (e.g., stigma, detrimental interactions with health care, and privacy concerns).
Jordon D. Bosse +6 more
doaj +1 more source